Last reviewed · How we verify
NCT05306262: CATALHYPNOANI
Interest of Catalepsy in the Hypnotic Trance
NA trial testing Hypnosis session in Hypnosis in 90 participants. Completed in 28 May 2022.
28 May 2022
Quick facts
| Lead sponsor | CMC Ambroise Paré |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 90 |
| Start date | 26 May 2022 |
| Primary completion | 28 May 2022 |
| Estimated completion | 28 May 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Hypnosis session
- Catalepsy
Conditions studied
- Hypnosis — all drugs for Hypnosis →
Sponsor
CMC Ambroise Paré — full company profile →
Who can join
Adults 18 to 75, any sex, with Hypnosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Catalepsy seems to facilitate hypnotic induction and deepen hypnotic trance, although no work confirms the usefulness of this technique which is in common use in hypnosis. Furthermore, it has been shown that the hypnotic trance state is accompanied by an increase in parasympathetic tone, the non-invasive measurement of which is easy by the ANI monitor (Analgesia Nociception Index). The research hypothesis is that, by adding a body dissociation, catalepsy could facilitate and intensify the hypnotic trance, the intensity of which can be monitored and is proportional to the parasympathetic tone.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05306262
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hypnosis session
Trials testing the same drug.
- NCT06972420 — Improving the Quality of Anesthesia Induction by Reducing Preoperative Anxiety in the Operating Room · NA · recruiting
- NCT04992598 — Hypnosis to Reduce Pain and Drugs for Shoulder Dislocation Management · NA · withdrawn
Other recruiting trials for Hypnosis
Currently open trials in the same condition.
- NCT07370974 — Effect of Clinical Hypnosis in Preoperative Anxiety Among Patients Undergoing an Abdominal Surgery. · NA · recruiting
- NCT06866457 — Audio Hypnosis for Reducing Anxiety in Children and Adolescents Undergoing MRI: A Randomized Controlled Trial · NA · recruiting
Other CMC Ambroise Paré trials
Trials by the same sponsor.
- NCT07477730 — Local Infiltration Analgesia Versus Quadruple Nerve Blocks in Total Knee Arthroplasty. · NA · not yet recruiting
- NCT07345559 — Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock · NA · recruiting
- NCT07332949 — Impact of Dialysis on Sexuality. · recruiting
- NCT06777355 — Association Between Portal Flow Pulsatility and Right Ventricular Dysfunction in the Postoperative Period of Cardiac Sur · completed
- NCT06327334 — Brain Heart InterActioNs in Cardiac Arrest. Ancillary Study of the HEAVENwARd Trial · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05306262 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CMC Ambroise Paré
- Last refreshed: 8 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05306262.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing